Perioperative Follow-up Protocols for Pelvic Organ Prolapse Surgery
NCT ID: NCT06631508
Last Updated: 2025-02-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
102 participants
INTERVENTIONAL
2025-03-01
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main questions it aims to answer are:
* Is the perioperative follow up protocol developed for women aged 30-65 having pelvic organ prolapse surgery effective?
* Does the developed perioperative follow up protocol for women aged 30-65 having pelvic organ prolapse surgery have an effect on quality of life, pelvic organ symptom score, sexual function, functional health patterns and anxiety?
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Anatomical Results and Sexual Functions After Unilateral and Bilateral Laparoscopic Suture Sacro-hysteropexy Operations
NCT06341088
Total Laparoscopic Hysterectomy With Sacrocolpopexy Versus Total Laparoscopic Hysterectomy With Lateral Suspension in Patients With Pelvic Organ Prolapse
NCT03722563
Vaginal Transluminal Endoscopic Sacrocolpopexy
NCT06004089
Effectiveness of Laparoscopic Lateral Suspension With or Without Hysterectomy in Pelvic Organ Prolapse
NCT07094815
Effectiveness of Perineorrhaphy in Pelvic Organ Prolapse Surgery
NCT07006129
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The sample of the research; It is planned to consist of a total of 102 women, 51 in the Follow-up Group and 51 in the Control Group, who meet the inclusion criteria and voluntarily agreed to participate in the research (Calculated using G.Power 3.1.7 program). After informed consent is obtained, full randomization technique will be used to assign participants to follow-up and control groups. Full randomization will be done via the website http://www.randomizer.org/. Two computer-generated randomization sequences will be applied on a one-to-one basis.
During the pre-test and post-test data collection phase, it is planned to use the 'Descriptive Characteristics Form', 'Pelvic Organ Prolapse Quality of Life Scale', 'Pelvic Organ Symptom Score', 'Pelvic Organ Prolapse/Urinary Incontinence Sexual Function Questionnaire Form', 'State-Trait Anxiety Inventory Short Version', and 'Functional Health Patterns Assessment Form' in the perioperative period.
After preoperative data is collected, the Follow-up Group will be shown a preoperative patient education video. In the postoperative period, Follow-up Group's data will be collected within 24-48 hours and the patient will be shown a postoperative education video before discharge. After discharge; at the 2nd, 6th, 10th and 14th weeks, Follow-up Group's will be followed up by phone and their data will be collected. In addition, a satisfaction form to evaluate the education videos will be applied to the Follow-up Group in the 14th week. The Control Group will not receive any intervention by the researcher and will receive routine perioperative care. Control Group's data will be collected in the preoperative and postoperative period. Additionally, Control Group's data will be collected by phone at the 2nd, 6th, 10th and 14th weeks after discharge and a postoperative education video will be watched after the data is collected at the 14th week.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Preoperative Period, Education video
Follow-up Group: Preoperative data of patients who will undergo pelvic organ prolapse surgery will be collected. Then, the preoperative patient education video will be watched. If patient has any questions will be answered.
Control Group: No intervention. Control Group's data will be collected.
Data collection forms to be used in the preoperative period:
* Introductory Characteristics Form
* Pelvic Organ Prolapse Quality of Life Scale
* Pelvic Organ Prolapse Symptom Score
* Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire
* State-Trait Anxiety Inventory Short Version
* Preoperative Functional Health Patterns Evaluation Form
Preoperative Period, Postoperative Period, 2th week after discharge, 6th week after discharge, 10th week after discharge, 14th week after discharge
Showing training videos to patients before and after pelvic organ prolapse surgery and following up after discharge
Postoperative Period, Education video
Patient data will be collected within 24-48 hours in the postoperative period. The postoperative patient education video will be watched before the patient is discharged. If patient has any questions, they will be answered.
Control Group: No intervention. Control Group's data will be collected.
Data collection forms to be used in the postoperative period:
* Postoperative Data Collection Form
* State-Trait Anxiety Inventory Short Version
* Postoperative Functional Health Patterns Evaluation Form
* Nursing Diagnoses Checklist After POP Surgery
Preoperative Period, Postoperative Period, 2th week after discharge, 6th week after discharge, 10th week after discharge, 14th week after discharge
Showing training videos to patients before and after pelvic organ prolapse surgery and following up after discharge
2th week after discharge
The patient's data will be collected by telephone follow-up two weeks after discharge.
Control Group: No intervention. Control Group's data will be collected.
Data collection forms to be used at the two weeks after discharge:
* Pelvic Organ Prolapse Quality of Life Scale
* Pelvic Organ Prolapse Symptom Score
* State-Trait Anxiety Inventory Short Version
* After Discharge Functional Health Patterns Evaluation Form
* Nursing Diagnoses Checklist After POP Surgery
Preoperative Period, Postoperative Period, 2th week after discharge, 6th week after discharge, 10th week after discharge, 14th week after discharge
Showing training videos to patients before and after pelvic organ prolapse surgery and following up after discharge
6th week after discharge
The patient's data will be collected by telephone follow-up six weeks after discharge.
Control Group: No intervention. Control Group's data will be collected.
Data collection forms to be used at the six weeks after discharge:
* Pelvic Organ Prolapse Quality of Life Scale
* Pelvic Organ Prolapse Symptom Score
* State-Trait Anxiety Inventory Short Version
* After Discharge Functional Health Patterns Evaluation Form
* Nursing Diagnoses Checklist After POP Surgery
Preoperative Period, Postoperative Period, 2th week after discharge, 6th week after discharge, 10th week after discharge, 14th week after discharge
Showing training videos to patients before and after pelvic organ prolapse surgery and following up after discharge
10th week after discharge
The patient's data will be collected by telephone follow-up ten weeks after discharge.
Control Group: No intervention. Control Group's data will be collected.
Data collection forms to be used at the ten weeks after discharge:
* Pelvic Organ Prolapse Quality of Life Scale
* Pelvic Organ Prolapse Symptom Score
* State-Trait Anxiety Inventory Short Version
* After Discharge Functional Health Patterns Evaluation Form
* Nursing Diagnoses Checklist After POP Surgery
Preoperative Period, Postoperative Period, 2th week after discharge, 6th week after discharge, 10th week after discharge, 14th week after discharge
Showing training videos to patients before and after pelvic organ prolapse surgery and following up after discharge
14th week after discharge
The patient's data will be collected by telephone follow-up fourteen weeks after discharge. Additionally, on the 14th week, a satisfaction form will be applied to the Follow-up Group to evaluate the education videos.
Control Group: No intervention. Control Group's data will be collected. After the data is collected, postoperative education video will be watched.
Data collection forms to be used at the fourteen weeks after discharge:
* Pelvic Organ Prolapse Quality of Life Scale
* Pelvic Organ Prolapse Symptom Score
* Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire
* State-Trait Anxiety Inventory Short Version
* After Discharge Functional Health Patterns Evaluation Form
* Nursing Diagnoses Checklist After POP Surgery
* Satisfaction Evaluation Form (Only Follow-up Group)
Preoperative Period, Postoperative Period, 2th week after discharge, 6th week after discharge, 10th week after discharge, 14th week after discharge
Showing training videos to patients before and after pelvic organ prolapse surgery and following up after discharge
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Preoperative Period, Postoperative Period, 2th week after discharge, 6th week after discharge, 10th week after discharge, 14th week after discharge
Showing training videos to patients before and after pelvic organ prolapse surgery and following up after discharge
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Being between 30-65 years old,
* Being sexually active,
* Ability to read and write,
* Ability to speak Turkish,
* Ability to use phone
* Having a phone that can be reached at all times and
* Agreeing to participate in the study
Exclusion Criteria
* Being between \<30 and \>65 years of age,
* Not being sexually active,
* Not being able to read and write,
* Not being able to speak Turkish,
* Inability to use the phone
* Not having a phone that can be reached at all times and
* Not agreeing to participate in the study
* Discontinue the research for any reason
30 Years
65 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Saglik Bilimleri Universitesi
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nazlı Özbek
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gulsah Kök
Role: STUDY_DIRECTOR
SBU Health Science Faculty Gulhane Nursing Faculty
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gulhane Training and Research Hospital
Ankara, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Hendrix SL, Clark A, Nygaard I, Aragaki A, Barnabei V, McTiernan A. Pelvic organ prolapse in the Women's Health Initiative: gravity and gravidity. Am J Obstet Gynecol. 2002 Jun;186(6):1160-6. doi: 10.1067/mob.2002.123819.
Weintraub AY, Glinter H, Marcus-Braun N. Narrative review of the epidemiology, diagnosis and pathophysiology of pelvic organ prolapse. Int Braz J Urol. 2020 Jan-Feb;46(1):5-14. doi: 10.1590/S1677-5538.IBJU.2018.0581.
Rogers RG, Coates KW, Kammerer-Doak D, Khalsa S, Qualls C. A short form of the Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12). Int Urogynecol J Pelvic Floor Dysfunct. 2003 Aug;14(3):164-8; discussion 168. doi: 10.1007/s00192-003-1063-2. Epub 2003 Jul 25.
Hagen S, Glazener C, Sinclair L, Stark D, Bugge C. Psychometric properties of the pelvic organ prolapse symptom score. BJOG. 2009 Jan;116(1):25-31. doi: 10.1111/j.1471-0528.2008.01903.x. Epub 2008 Oct 8.
Digesu GA, Khullar V, Cardozo L, Robinson D, Salvatore S. P-QOL: a validated questionnaire to assess the symptoms and quality of life of women with urogenital prolapse. Int Urogynecol J Pelvic Floor Dysfunct. 2005 May-Jun;16(3):176-81; discussion 181. doi: 10.1007/s00192-004-1225-x. Epub 2004 Oct 21.
Zhang T, Qi X. Enhanced Nursing Care for Improving the Self-Efficacy & Health-Related Quality of Life in Patients with a Urostomy. J Multidiscip Healthc. 2023 Jan 29;16:297-308. doi: 10.2147/JMDH.S394515. eCollection 2023.
Rockefeller NF, Jeppson P, Komesu YM, Meriwether KV, Ninivaggio C, Dunivan G. Preferences for Preoperative Education: A Qualitative Study of the Patient Perspective. Female Pelvic Med Reconstr Surg. 2021 Oct 1;27(10):633-636. doi: 10.1097/SPV.0000000000001014.
Richardson K, Hagen S. The role of nurses in the management of women with pelvic organ prolapse. Br J Nurs. 2009 Mar 12-25;18(5):294-6, 298-300. doi: 10.12968/bjon.2009.18.5.40710.
Haya N, Feiner B, Baessler K, Christmann-Schmid C, Maher C. Perioperative interventions in pelvic organ prolapse surgery. Cochrane Database Syst Rev. 2018 Aug 19;8(8):CD013105. doi: 10.1002/14651858.CD013105.
Belayneh T, Gebeyehu A, Adefris M, Rortveit G, Gjerde JL, Ayele TA. Pelvic organ prolapse surgery and health-related quality of life: a follow-up study. BMC Womens Health. 2021 Jan 2;21(1):4. doi: 10.1186/s12905-020-01146-8.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
nozbek
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.